Care partners for multiple myeloma patients emphasize that managing their own mental health is not a luxury, but a necessity ...
Longer-term results from the BENEFIT trial show sustained minimal residual disease negativity in newly diagnosed, ...
Colleen Mabasa, a patient with multiple myeloma, discusses her CAR T-cell therapy journey and the pivotal role self-advocacy ...
Discover the latest breakthroughs in multiple myeloma treatment, including CAR T-cell therapies and promising new options for ...
Experts discuss the critical challenges in accessing innovative treatments for relapsed refractory multiple myeloma, ...
Peter Voorhees, MD, emphasizes the importance of carefully determined early regimens for smoldering myeloma and involving ...
MedPage Today on MSN
Zeroing in on the disparities in multiple myeloma care, outcomes
Estimates based on the most recent data from the NCI's Surveillance, Epidemiology, and End Results (SEER) program show that ...
Your doctor tells you your multiple myeloma is in remission. But what exactly does that mean? The first thing to understand is that being in remission is not the same thing as being cured. The ...
U.S. IND represents the second regulatory clearance for KLN-1010 and enables the first multi-center clinical trial in the U.S ...
If your doctor tells you that you're having a relapse, it means your multiple myeloma came back after your treatment left you cancer-free for a while. If this happens to you, keep in mind that there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback